“Use of active surveillance has increased over the last 15 years for men with low-risk prostate cancer, and it is now the ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

According to the 2019 National Cancer Registry the lifetime risk for prostate cancer in South Africa is 1 in every 15 man. Prostate cancer is the most common cancer in men globally and is showing a ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

Sir Chris Hoy has been diagnosed with terminal prostate cancer and the Olympic hero has vowed he still has a "lot of life ...

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Specific screenings such as imaging for kidney, adrenal, bladder, and testicular cancers, PSA tests for prostate cancer, and ...

Nuclearelectrica (BVB: SNN) and France's Framatome have signed an agreement to produce the medical isotope Lutetium-177 ...

Sir Chris Hoy ’s wife Lady Sarra has revealed the guilt she felt when she hid her own illness from her husband.